{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T18:34:38Z","timestamp":1775586878096,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmig.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Minimally Invasive Gynecology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.jmig.2006.07.007","type":"journal-article","created":{"date-parts":[[2006,11,9]],"date-time":"2006-11-09T07:23:22Z","timestamp":1163057002000},"page":"539-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["GnRH analogs: Options for endometriosis-associated pain treatment"],"prefix":"10.1016","volume":"13","author":[{"given":"Frances R.","family":"Batzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmig.2006.07.007_bib1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0015-0282(00)00519-7","article-title":"Medical management of endometriosis and infertility","volume":"73","author":"Lessey","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2007-1018824","article-title":"The use of GNRH agonists in the medical therapy of endometriosis in the woman with pain","volume":"11","author":"Emmi","year":"1993","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.jmig.2006.07.007_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0889-8545(02)00057-8","article-title":"Medical management of endometriosis-associated pain","volume":"30","author":"Mahutte","year":"2003","journal-title":"Obstet Gynecol Clin N Am"},{"key":"10.1016\/j.jmig.2006.07.007_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0015-0282(97)81391-X","article-title":"Revised American Society for Reproductive Medicine classification of endometriosis: 1996","volume":"67","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0015-0282(16)53232-4","article-title":"Stage and localization of pelvic endometriosis and pain","volume":"53","author":"Fedele","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0015-0282(16)58089-3","article-title":"Endometriosis and pelvic pain: relation to disease stage and localization","volume":"65","author":"Vercellini","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0015-0282(01)02736-4","article-title":"Validation study of nonsurgical diagnosis of endometriosis","volume":"76","author":"Eskenazi","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198802253180805","article-title":"Administration of nasal Nafarelin as compared with oral danazol for endometriosis: a multicenter double-blind comparative clinical trial","volume":"318","author":"Henzl","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmig.2006.07.007_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/09513598709082692","article-title":"Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis","volume":"1","author":"Telimaa","year":"1987","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jmig.2006.07.007_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0015-0282(16)55205-4","article-title":"An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis: Zoladex Endometriosis Study Team","volume":"58","author":"Shaw","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0002-9378(11)91718-9","article-title":"Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis","volume":"167","author":"Wheeler","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2006.07.007_bib12","first-page":"198","article-title":"Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol","volume":"82","author":"Rock","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2006.07.007_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1074-3804(05)80157-4","article-title":"The efficacy of drugs in the management of endometriosis","volume":"3","author":"Bulletti","year":"1996","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"10.1016\/j.jmig.2006.07.007_bib14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00006250-200504000-00058","article-title":"Committee Opinion. Endometriosis in Adolescents. ACOG Committee Opinion No. 310","volume":"105","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2006.07.007_bib15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-4731(85)80005-4","article-title":"Molecular mechanisms of gonadotropin-releasing hormone action","volume":"23","author":"Conn","year":"1987","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.jmig.2006.07.007_bib16","first-page":"645","article-title":"Treatment options for endometriosis","volume":"3","author":"Hurst","year":"1992","journal-title":"Infertility and Reproductive Medical Clinics of North America"},{"key":"10.1016\/j.jmig.2006.07.007_bib17","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/humrep\/deg356","article-title":"Effect of GnRH analogues on apoptosis and release of interleukin-1\u03b2 and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis","volume":"18","author":"Meresman","year":"2005","journal-title":"Hum Reprod"},{"issue":"Suppl. 2","key":"10.1016\/j.jmig.2006.07.007_bib18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0015-0282(03)00769-6","article-title":"Gonadotropin-releasing hormone agonist (GnRH-a) induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis","volume":"80","author":"Meresman","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/humupd\/6.1.45","article-title":"Vascular endothelial growth factor and endometriotic angiogenesis","volume":"6","author":"McLaren","year":"2000","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jmig.2006.07.007_bib20","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/humrep\/13.6.1686","article-title":"Vascular endothelial growth factor (VEGF) in endometriosis","volume":"13","author":"Donnez","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmig.2006.07.007_bib21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1600-0897.1997.tb00319.x","article-title":"Peritoneal cellular immunity and endometriosis","volume":"38","author":"Wu","year":"1997","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jmig.2006.07.007_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/molehr\/6.3.269","article-title":"Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1\u03b2","volume":"6","author":"Lebovic","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.jmig.2006.07.007_bib23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0015-0282(03)00609-5","article-title":"Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriosis","volume":"80","author":"Iwabe","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0015-0282(00)00712-3","article-title":"Quantitative analysis of estrogen receptor alpha and beta messenger ribonucleic acid levels in normal endometrium and ovarian endometriotic cysts using a real-time reverse transcription-polymerase chain reaction assay","volume":"74","author":"Matsuzaki","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.fertnstert.2003.12.044","article-title":"Gonadotropin-releasing hormone agonist inhibits Estrone sulfatase expression of cystic endometriosis in the ovary","volume":"82","author":"Maitoko","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib26","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.fertnstert.2005.09.061","article-title":"Effect of gonadotropin-releasing hormone agonist and antagonist on proliferation and apoptosis of human luteinized granulosa cells","volume":"85","author":"Vitale","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0015-0282(02)04813-6","article-title":"Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas","volume":"79","author":"Ishihara","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib28","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.fertnstert.2005.09.028","article-title":"Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and infertility","volume":"85","author":"Wang","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1126\/science.100883","article-title":"Hypophysial responses to continuous and intermittent delivery of hypophthalamic gonadotropin-releasing hormone","volume":"202","author":"Belchetz","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.jmig.2006.07.007_bib30","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1067\/mob.2000.106846","article-title":"Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial","volume":"182","author":"Miller","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2006.07.007_bib31","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0015-0282(16)57963-1","article-title":"Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women","volume":"64","author":"Gelety","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0015-0282(16)60121-8","article-title":"Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression","volume":"50","author":"Meldrum","year":"1988","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib33","first-page":"215","article-title":"Pain of endometriosis: effects of Nafarelin and danazol therapy","volume":"39","author":"Adamson","year":"1994","journal-title":"Int J Fertil Menopausal Stud"},{"key":"10.1016\/j.jmig.2006.07.007_bib34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0015-0282(16)55792-6","article-title":"Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study","volume":"59","author":"Fedele","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0015-0282(16)53755-8","article-title":"Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study","volume":"54","author":"Dlugi","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0002-9378(90)90437-C","article-title":"Nafarelin versus danazol in the treatment of endometriosis","volume":"162","author":"Rolland","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2006.07.007_bib37","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0015-0282(16)53574-2","article-title":"A comparison of nafarelin acetate and danazol in the treatment of endometriosis","volume":"53","author":"Kennedy","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib38","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0002-9378(89)90739-4","article-title":"Buserelin versus danazol in the treatment of endometriosis-associated infertility","volume":"161","author":"Fedele","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2006.07.007_bib39","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0002-9378(90)90433-8","article-title":"Nafarelin in the treatment of pelvic pain caused by endometriosis","volume":"162","author":"Shaw","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2006.07.007_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0015-0282(16)54893-6","article-title":"Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1 year follow-up: the Nafarelin European Endometriosis Trial Group (NEET)","volume":"57","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/09513590009167714","article-title":"A comparative study of the acceptability and effect of goserelin and Nafarelin on endometriosis","volume":"14","author":"Bergquist","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jmig.2006.07.007_bib42","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0015-0282(98)00019-3","article-title":"Effects of triptorelin versus placebo controlled, double-blind study","volume":"69","author":"Bergqvist","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02106098","article-title":"Bone loss during GnRH agonist treatment and use of nasal salmon calcitonin","volume":"5","author":"Roux","year":"1995","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jmig.2006.07.007_bib44","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0015-0282(98)00086-7","article-title":"Goserelin acetate (Zoladex) with and without hormone replacement therapy for the treatment of endometriosis","volume":"69","author":"Moghissi","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0029-7844(97)00620-0","article-title":"Leuprolide acetate depot and hormonal add-back in endometriosis: a 12 month study","volume":"91","author":"Hornstein","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2006.07.007_bib46","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0015-0282(00)00690-7","article-title":"Gonadotropin-releasing hormone agonist plus \u201cadd-back\u201d hormone replacement therapy for treatment of endometriosis: a prospective randomized, placebo-controlled, double-blind trial","volume":"74","author":"Franke","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib47","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/jcem-70-4-920","article-title":"Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing agonists?","volume":"70","author":"Riis","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jmig.2006.07.007_bib48","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0015-0282(16)53453-0","article-title":"The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis","volume":"53","author":"Surrey","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib49","first-page":"530","article-title":"Impact of six months of GnRH agonist therapy for endometriosis","volume":"47","author":"Agarwal","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jmig.2006.07.007_bib50","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0015-0282(16)58200-4","article-title":"Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment","volume":"65","author":"Paoletti","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib51","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0015-0282(00)01537-5","article-title":"Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6 year follow-up","volume":"74","author":"Pierce","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.fertnstert.2003.05.022","article-title":"Prediction of the change in bone mineral density induced by gonadotropin-releasing hormone agonist treatment for endometriosis","volume":"81","author":"Matsuo","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib53","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/0002-9378(92)91706-G","article-title":"Hormone treatment of endometriosis: the estrogen threshold hypothesis","volume":"166","author":"Barbieri","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2006.07.007_bib54","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/humrep\/deh250","article-title":"One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial","volume":"19","author":"Fernandez","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmig.2006.07.007_bib55","first-page":"709","article-title":"Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: Long-term follow-up","volume":"99","author":"Surrey","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2006.07.007_bib56","first-page":"558","article-title":"Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial","volume":"75","author":"Surrey","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jmig.2006.07.007_bib57","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0015-0282(16)57476-7","article-title":"Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone \u201cadd-back\u201d therapy","volume":"63","author":"Surrey","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0002-9378(96)70258-2","article-title":"A randomized, placebo-controlled study on the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated with six months of gonadotropin-releasing hormone agonist treatment","volume":"175","author":"Mukherjee","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2006.07.007_bib59","first-page":"15","article-title":"Should add-back therapy for endometriosis be deferred for optimal results?","volume":"103","author":"Kiesel","year":"1996","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2006.07.007_bib60","first-page":"413","article-title":"Nafarelin vs. leuprolide acetate depot for endometriosis: changes in bone mineral density and vasomotor symptoms","volume":"42","author":"Agarwal","year":"1997","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jmig.2006.07.007_bib61","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1701-2163(16)30206-7","article-title":"Gonadotropin releasing hormone and reproductive medicine","volume":"25","author":"Shalev","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jmig.2006.07.007_bib62","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1749-6632.2002.tb02795.x","article-title":"Conventional medical therapies for endometriosis","volume":"955","author":"Rice","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jmig.2006.07.007_bib63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1472-6483(10)61590-8","article-title":"Use of GnRH antagonists in the treatment of endometriosis","volume":"5","author":"K\u00fcpker","year":"2002","journal-title":"Reproductive BioMedicine On Line"},{"key":"10.1016\/j.jmig.2006.07.007_bib64","article-title":"Dose-finding study of the LHRH antagonist cetrorelix, given over a period of 8 weeks, in the treatment of endometriosis","volume":"6","author":"Donnez","year":"2004","journal-title":"Evidence Based Obstet Gynecol"},{"key":"10.1016\/j.jmig.2006.07.007_bib65","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1093\/humrep\/dei192","article-title":"GnRH II as a possible cytostatic regulator in the development of endometriosis","volume":"20","author":"Morimoto","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmig.2006.07.007_bib66","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0015-0282(97)00360-9","article-title":"Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis","volume":"68","author":"Hornstein","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2006.07.007_bib67","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1471-0528.1999.tb08366.x","article-title":"A gonadotrophin releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis","volume":"106","author":"Vercellini","year":"1999","journal-title":"Br J Obstet Gynaecol"}],"container-title":["Journal of Minimally Invasive Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465006003542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465006003542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T19:08:15Z","timestamp":1754507295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553465006003542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1553465006003542"],"URL":"https:\/\/doi.org\/10.1016\/j.jmig.2006.07.007","relation":{},"ISSN":["1553-4650"],"issn-type":[{"value":"1553-4650","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GnRH analogs: Options for endometriosis-associated pain treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Minimally Invasive Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmig.2006.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 AAGL. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}